Instalab
logoInstalab

BMI

See whether your weight is quietly raising your risk for heart disease, diabetes, and over a dozen cancers, even if you feel fine.

Should you take a BMI test?

This test is most useful if any of these apply to you.

Watching Your Weight Trend
Track whether your weight trajectory is heading toward or away from metabolic risk over time.
Concerned About Diabetes Risk
Your BMI is one of the strongest predictors of type 2 diabetes, often years before blood sugar changes.
Building Muscle Through Training
Pair with waist circumference or DEXA to see if your changing weight reflects muscle gain, not fat.
Keeping Tabs on Heart Health
Even modest BMI increases raise cardiovascular risk; tracking the trend helps you act early.

About BMI

Your BMI (body mass index) is one of the simplest numbers in medicine, and one of the most consequential. It takes two measurements you already know (your weight and height), divides one by the other, and produces a single score that predicts your risk for dozens of diseases. A large analysis of over 10 million people found that for every 5-unit increase in BMI above 25, the risk of dying from any cause rose by about 31%. The diseases tied to elevated BMI span nearly every organ system: heart disease, stroke, type 2 diabetes, chronic kidney disease, sleep apnea, liver disease, and at least 13 types of cancer.

But BMI is also imperfect in ways that matter. It cannot tell you whether your weight comes from muscle or fat, and it cannot tell you where your fat sits. Two people with the same BMI can have very different metabolic profiles depending on whether their fat is concentrated around their organs or distributed under the skin. Knowing these limitations makes you a smarter user of the number, not a reason to ignore it.

What BMI Actually Tells You

BMI is calculated by dividing your weight in kilograms by your height in meters squared. It is not a direct measurement of body fat. Instead, it serves as a rough proxy for total body fatness at the population level. A meta-analysis of 32 studies found that BMI correctly identified people with excess fat about 50% of the time (50% sensitivity) with a specificity of about 90%. A more recent analysis using DEXA-measured body fat in over 10,000 U.S. adults found higher sensitivity (about 75%) and specificity (about 82%) when using standard BMI cutpoints. In practice, that means a high BMI almost always means excess body fat, but a normal BMI does not guarantee healthy body composition.

The fat tissue itself is not inert. Fat cells produce hormones and signaling molecules that affect your metabolism, inflammation levels, and blood vessel health. Among the most strongly linked to BMI are leptin (a hunger-regulating hormone that rises as fat mass increases) and a protein called FABP4 that tracks closely with body fat. At the same time, a molecule called SHBG (sex hormone-binding globulin), which helps regulate sex hormones in both men and women, tends to fall as BMI rises.

Heart Disease and Stroke

Carrying extra weight strains your heart and blood vessels through several channels at once: it raises blood pressure, worsens cholesterol balance, and pushes blood sugar higher. A pooled analysis of 97 large studies, tracking 1.8 million people, found that each 5-unit increase in BMI raised coronary heart disease risk by about 27% and stroke risk by about 18%. When the researchers adjusted for blood pressure, blood sugar, and cholesterol, about half of the excess coronary risk and three-quarters of the stroke risk disappeared, confirming that these metabolic changes are the primary routes through which excess weight damages the cardiovascular system.

A more recent analysis of nearly 290,000 people followed for about 19 years found that people with class 2 obesity (BMI 35 to 39.9) had roughly double the risk of heart failure and significantly higher rates of coronary disease and stroke compared to those with normal weight, even after accounting for standard cardiovascular risk factors.

Type 2 Diabetes

The connection between BMI and type 2 diabetes is among the strongest in all of medicine. A meta-analysis covering 26 million people found that each 5-unit increase in BMI raised diabetes risk by 72%. When researchers compared categories directly, people with obesity were about 7 times more likely to develop diabetes than people with normal weight, and even those who were simply overweight faced roughly 3 times the risk. The relationship is nearly linear: there is no safe threshold below which additional weight stops mattering.

Timing matters too. A study tracking children from age 7 through adulthood found that being overweight as a child and remaining overweight into early adulthood carried the highest diabetes risk. But children who were overweight and then normalized their weight before adulthood did not have elevated risk, suggesting that the trajectory of your BMI over time matters as much as any single reading.

Cancer Risk

The International Agency for Research on Cancer has identified 13 cancer types linked to excess body fat. The strongest associations are with endometrial cancer, where the risk climbs steeply with BMI: roughly 1.5 times higher for people who are overweight, 2.5 times for class 1 obesity, 4.5 times for class 2, and about 7 times higher for class 3 obesity compared to normal weight. Esophageal cancer (specifically a type called adenocarcinoma) shows similarly dramatic increases, with risk reaching nearly 5 times higher at BMI 40 or above.

Data from about 500,000 adults in the China Kadoorie Biobank confirmed these patterns in an East Asian population: each 5-unit BMI increase raised endometrial cancer risk by roughly double, postmenopausal breast cancer risk by about 29%, and colorectal cancer risk by about 17%.

Mortality: The J-Shaped Curve

The relationship between BMI and death risk follows what statisticians call a J-shaped curve: risk is elevated at both very low and very high BMI, with a sweet spot in the middle. The largest analysis, pooling data from 239 studies and 10.6 million people, found the lowest death risk in the BMI range of 20 to 25 among people who never smoked and had no pre-existing chronic disease. The optimal point shifts slightly with age: around BMI 22 for adults aged 35 to 49, BMI 23 for those 50 to 69, and BMI 24 for those 70 to 89.

A separate meta-analysis of 230 studies and over 30 million participants confirmed that the lowest mortality sits around BMI 23 to 24 in never-smokers. Studies that seem to show an advantage for being slightly overweight typically include smokers (who tend to be thinner and die younger) and people already ill with diseases that cause weight loss, which creates a statistical illusion.

Low BMI carries its own risks, primarily from respiratory infections, frailty, and wasting. About 39% of deaths attributed to high BMI occur in people who are overweight but not yet obese (BMI 25 to 30), a reminder that the health consequences of excess weight begin well before reaching the obesity threshold.

Reference Ranges

BMI cutpoints differ significantly by ethnicity, because body fat distribution and metabolic consequences vary across populations. The standard categories most commonly used in Western countries were established by the World Health Organization.

CategoryBMI Range (kg/m²)What It Suggests
UnderweightBelow 18.5May signal malnutrition, frailty, or underlying illness; associated with increased infection and mortality risk
Normal weight18.5 to 24.9Lowest mortality risk across studies; sweet spot for metabolic health in most populations
Overweight25.0 to 29.9Modestly elevated risk for heart disease, diabetes, and some cancers; risk rises further toward the upper end
Class 1 obesity30.0 to 34.9Meaningfully elevated metabolic and cardiovascular risk; weight loss of 5 to 10% produces measurable health benefits
Class 2 obesity35.0 to 39.9Substantially elevated risk across multiple organ systems
Class 3 obesity40.0 and aboveHighest risk category; strongest associations with diabetes, heart failure, and certain cancers

These cutpoints were developed primarily in European-descent populations. If you are of South Asian, East Asian, or Southeast Asian descent, metabolic complications begin at lower BMI values. A large UK study found that the BMI at which South Asian individuals reach the same diabetes risk as a White individual at BMI 30 is just 23.9. For Chinese populations, the equivalent threshold is about 26.9, and for Black populations about 28.1. Many Asian countries use 23 as the overweight threshold and 25 or higher as the obesity threshold.

What BMI Misses

The single biggest blind spot is body composition. BMI cannot distinguish muscle from fat. A competitive athlete with substantial muscle mass may register as overweight or even obese by BMI while having very low body fat. More dangerously, a person with normal BMI but high abdominal fat (sometimes called "normal-weight obesity") may face elevated cardiovascular and metabolic risk that BMI completely misses. About 20 to 30% of people with a normal BMI have metabolic abnormalities, and their risk of cardiovascular events is about three times higher than metabolically healthy people at the same BMI.

Waist circumference catches what BMI misses. At any given BMI, people with larger waist measurements have significantly higher death rates than those with smaller waists. Current guidelines recommend measuring waist circumference alongside BMI, especially when BMI falls between 25 and 35. Risk thresholds are 102 cm (about 40 inches) for men and 88 cm (about 35 inches) for women in most populations, with lower cutpoints (94 cm for men, 80 cm for women) for Asian, Middle Eastern, and Mediterranean populations.

Tracking Your Trend

A single BMI reading tells you where you stand. A series of readings tells you where you are headed, which is far more useful. Someone whose BMI is 26 and has been stable for five years is in a very different situation than someone whose BMI has climbed from 23 to 26 over the same period. The second person is on a trajectory that, if unchecked, leads to meaningful metabolic consequences within a few years.

Track your BMI at least annually. If you are actively making dietary or exercise changes, weigh yourself consistently (same time of day, same conditions) and recalculate every one to three months. The goal is not to obsess over daily fluctuations, which can swing by 1 to 2 kg from water, food timing, and activity. The goal is to see the slope of the line over months and years. Research on childhood overweight shows that the trajectory matters enormously: children who normalized their weight before adulthood eliminated their excess diabetes risk entirely. The same principle applies to adults.

If you are making changes and your BMI is not moving, consider pairing it with waist circumference or a body composition measurement like DEXA. You may be gaining muscle while losing fat, which is excellent progress that BMI will not capture.

When BMI Can Be Misleading

Beyond the muscle-versus-fat issue, several factors can make a BMI reading unrepresentative of your actual metabolic risk. Fluid retention from heart failure, kidney disease, or certain medications can inflate your weight and push BMI higher without any change in body fat. Conversely, dehydration can make BMI appear lower than it truly is. Age-related muscle loss (sarcopenia) means that older adults may have a normal or even low BMI while carrying excess fat relative to muscle, a combination that carries higher health risk than the number suggests.

Pregnancy, recent surgery, and acute illness all make BMI temporarily unreliable. If you have had a major change in health status, wait until you have returned to your usual state before using BMI as a tracking tool.

What Moves This Biomarker

Evidence-backed interventions that affect your BMI level

Decrease
Take semaglutide 2.4 mg weekly (a GLP-1 receptor agonist medication)
Average weight loss of 14.9% at 16 months, with a 13.5 cm reduction in waist circumference. Network meta-analysis showed over 9 times higher odds of achieving at least 5% weight loss compared to placebo.
MedicationStrong Evidence
Decrease
Take tirzepatide 15 mg weekly (a dual GIP/GLP-1 receptor agonist)
Produces the largest weight reduction among currently approved anti-obesity medications. Specific percentage data available from randomized trials.
MedicationStrong Evidence
Decrease
Follow a low-fat vegan or vegetarian diet (10 to 25% of calories from fat)
In a meta-analysis of 12 randomized trials, vegetarian diets produced about 2 kg more weight loss than control diets, with vegan diets showing the largest effect (about 2.5 kg). Individual trials of low-fat vegan diets with energy restriction have shown losses of 5 to 7 kg over 16 weeks. Also improved insulin sensitivity.
DietStrong Evidence
Decrease
Follow a ketogenic diet
Ranked as the most effective dietary pattern for BMI reduction in a network meta-analysis of 17 randomized trials with 5,802 participants, followed by low-fat, low-calorie, and Mediterranean approaches.
DietModerate Evidence
Decrease
Follow a low-carbohydrate diet (less than 40% of calories from carbohydrates)
Mean weight loss of 5.0 kg at 12 months compared to control. Also decreased blood pressure, glucose, insulin resistance, and triglycerides.
DietModerate Evidence
Decrease
Create a daily caloric deficit of 500 to 750 calories
Recommended target of 1,200 to 1,500 kcal/day for most women and 1,500 to 1,800 kcal/day for most men. Forms the foundation of most successful weight-loss programs.
DietModerate Evidence
Decrease
Do moderate-intensity aerobic exercise (such as brisk walking, cycling, or swimming)
Dose-response relationship: about 2.8 kg weight loss at 150 minutes per week, increasing to about 4.2 kg at 300 minutes per week. Also reduces visceral fat. Average effective protocol was about 50 minutes per session, 4 times per week, for 22 weeks.
ExerciseModerate Evidence
Decrease
Take liraglutide 3.0 mg daily
Average weight loss of 8.0% at 12 months with blood pressure reduction of about 4.2 mmHg and 3.0% LDL cholesterol reduction.
MedicationModerate Evidence
Increase
Take corticosteroids (such as prednisone or dexamethasone)
Causes weight gain through increased appetite, altered fat distribution (particularly abdominal and facial), and metabolic changes. Effects are dose-dependent and increase with duration of use.
MedicationModerate Evidence
Increase
Take certain antipsychotic medications (such as olanzapine or quetiapine)
Olanzapine associated with about 2.4 kg weight gain, quetiapine with about 1.1 kg, and risperidone with about 0.8 kg in meta-analysis data.
MedicationModerate Evidence
Decrease
Follow a Mediterranean diet
Mean weight loss of 2.5 kg at 12 months compared to control. Also improved blood pressure, LDL cholesterol, HbA1c, and triglycerides.
DietModest Evidence
Decrease
Use high-protein meal replacement shakes or bars for 1 to 2 meals daily
Improved weight loss by about 1.44 kg compared to diet alone.
DietModest Evidence
Increase
Take certain antidepressants (such as amitriptyline or mirtazapine)
Amitriptyline associated with about 1.8 kg weight gain and mirtazapine with about 1.5 kg. Bupropion, by contrast, is associated with about 1.3 kg weight loss.
MedicationModest Evidence
Increase
Take a statin
Modest weight gain of approximately 0.24 to 0.33 kg over 4 years, likely through effects on metabolism via the same enzyme pathway the drug targets for cholesterol lowering.
MedicationModest Evidence
Increase
Take a proton pump inhibitor (PPI) for acid reflux
Associated with about 2.2 kg weight gain over 2.2 years in patients with gastroesophageal reflux disease.
MedicationModest Evidence

Frequently Asked Questions

References

56 studies
  1. Gadde KM, Martin CK, Berthoud HR, Heymsfield SBJournal of the American College of Cardiology2018
  2. Lustig RH, Collier D, Kassotis CBiochemical Pharmacology2022
  3. Heymsfield SB, Wadden TAThe New England Journal of Medicine2017
  4. Goudswaard LJ, Bell JA, Hughes DAInternational Journal of Obesity2021